Modus Operandi

Most Recent

image: Rewritten in Blood

Rewritten in Blood

By | September 1, 2014

A modified gene-editing technique corrects mutations in human hematopoietic stem cells.

0 Comments

image: Stressing and FRETing

Stressing and FRETing

By | August 1, 2014

Two labs have produced FRET-based systems for real-time analysis of a plant stress hormone.

0 Comments

image: Laser-Guided Chastity

Laser-Guided Chastity

By | July 1, 2014

Scientists devise a precision-targeted system for training, tracking, and tweaking fruit fly social behavior.

1 Comment

image: Film Stars

Film Stars

By | June 1, 2014

Engineered bacteria can shape electricity-conducting nanowires.

0 Comments

image: Fuel Gauge

Fuel Gauge

By | May 1, 2014

An optical reporter quantitatively measures the ATP demands of presynaptic neurons.

2 Comments

image: Molecular Multitasker

Molecular Multitasker

By | April 1, 2014

Scientists create a way to isolate mRNA from a single living cell within a tissue.

0 Comments

image: Tension Tracker

Tension Tracker

By | March 1, 2014

For the first time, researchers quantify the mechanical forces cells exert on one another.

0 Comments

image: Visualizing Viruses

Visualizing Viruses

By | February 1, 2014

Scientists devise a gentler technique for observing viral DNA at single-molecule resolution.

0 Comments

image: Exit Strategy

Exit Strategy

By | January 1, 2014

Scientists come up with a better way to watch cells leave blood vessels.

0 Comments

image: Proto-Organelles for Synthetic Cells

Proto-Organelles for Synthetic Cells

By | December 1, 2013

Researchers construct lipid-encapsulated compartments within synthetic cells.

2 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham